英国队列研究:哮喘间歇口服糖皮质激素处方模式与不良结局的关联
结果显示,间歇OCS处方越频繁,任何不良结局风险越高(频繁组HR 1.42,95%CI 1.42-1.43),肺炎和睡眠呼吸暂停风险最高。
要点
- 间歇OCS处方模式中频繁者占31.6%,低频者占26.8%,一次性者占41.7%。
- 与无OCS相比,一次性、低频、频繁OCS的任意不良结局HR分别为1.19、1.35、1.42。
- 肺炎和睡眠呼吸暂停的风险随OCS处方频率增加而最高。
核心结论
- 间歇OCS处方模式越频繁,哮喘患者OCS相关不良结局风险越高,且在各年龄、GINA治疗步级及ICS/SABA亚组中一致。
研究设计与样本
- 历史性英国队列研究(2008-2019),使用OPCRD和CPRD两个初级保健数据库,纳入≥4岁仅接受间歇OCS的哮喘患者,并按1:1匹配非OCS对照。
主要发现
- 与无OCS相比,一次性、低频、频繁OCS的任意不良结局HR(95%CI)分别为1.19(1.18-1.20)、1.35(1.34-1.36)、1.42(1.42-1.43)。
- 肺炎和睡眠呼吸暂停是随OCS处方频率增加风险最高的个体不良结局。
临床怎么用
- 初级保健中应尽量减少间歇OCS处方,以降低哮喘患者不良结局风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Oral corticosteroids (OCS) for asthma are associated with increased risks of developing adverse outcomes (adverse outcomes); no previous study has focused exclusively on intermittent OCS use. METHODS: This historical (2008-2019) UK cohort study using primary care medical records from two anonymised, real-life databases (OPCRD and CPRD) included patients aged≥4 years with asthma receiving only intermittent OCS. Patients were indexed on their first recorded intermittent OCS prescription for asthma and categorised by OCS prescribing patterns: one-off (single), less frequent (≥90 day gap) and frequent (<90 day gap). Non-OCS patients matched 1:1 on gender, age and index date served as controls. The association of OCS prescribing patterns with OCS-related AO risk was studied, stratified by age, Global Initiative for Asthma (GINA) 2020 treatment step, and pre index inhaled corticosteroid (ICS) and short-acting β2-agonist (SABA) prescriptions using a multivariable Cox-proportional hazard model. FINDINGS: Of 476 167 eligible patients, 41.7%, 26.8% and 31.6% had one-off, less frequent and frequent intermittent OCS prescribing patterns, respectively. Risk of any AO increased with increasingly frequent patterns of intermittent OCS versus non-OCS (HR; 95% CI: one-off 1.19 (1.18 to 1.20), less frequent 1.35 (1.34 to 1.36), frequent 1.42 (1.42 to 1.43)), and was consistent across age, GINA treatment step and ICS and SABA subgroups. The highest risks of individual OCS-related adverse outcomes with increasingly frequent OCS were for pneumonia and sleep apnoea. CONCLUSION: A considerable proportion of patients with asthma receiving intermittent OCS experienced a frequent prescribing pattern. Increasingly frequent OCS prescribing patterns were associated with higher risk of OCS-related adverse outcomes. Mitigation strategies are needed to minimise intermittent OCS prescription in primary care.
引用
- Heatley H, Tran TN, Bourdin A, et al. Observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthma. Thorax. 2022. PMID: 36575040. doi:10.1136/thorax-2022-219642
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。